Research

Hormonal

Naltrexone/bupropion increased proglucagon levels and decreased GLP-2, glucagon, and the major proglucagon fragment.

Naltrexone/bupropion may be beneficial for altering specific hormone levels related to metabolism.

StrongSupportsmedium confidence
Naltrexone/bupropion produced a weight-independent increase in the levels of proglucagon (P < .001) and decreases in glucagon-like peptide-2 (GLP-2), glucagon and the major proglucagon fragment (P ≤ .01).
Konstantinos Stefanakis et al. · Diabetes Obesity and Metabolism · 2023

Why this rating

Based on the interventional study design with statistical significance reported.

Source

Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study

Konstantinos Stefanakis et al. · Diabetes Obesity and Metabolism · 2023

DOI 10.1111/dom.15141

rct · n=17Cited 15×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →